Surfactant Protein-C Regulates Alveolar Type 2 Epithelial Cell Lineages via the CD74 Receptor
Journal of Respiratory Biology and Translational Medicine · 2024
DOI: 10.70322/jrbtm.2024.10017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Respiratory Biology and Translational Medicine, 2024. Verfasst von Krishan G Jain und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Background
Deficiency of surfactant protein-C (SPC) increases susceptibility to lung infections and injury, and suppressed expression of SPC has been associated with the severity of acute respiratory distress syndrome (ARDS). Alveolar type 2 epithelial cells (AT2) are critical for maintenance and repair of the lung. However, the role of the SPC in the regulation of AT2 cell lineage and the underlying mechanisms are not completely understood.
Methods
This study aimed to investigate the mechanisms by which SPC regulates AT2 lineages. Sftpc-/- mice were used to model the SPC deficiency in ARDS patients. We utilized three-dimensional (3D) organoids to compare AT2 lineage characteristics between wild type (WT) and Sftpc-/- mice by analyzing AT2 proliferation, alveolar type 1 cells (AT1) differentiation and CD74 expression, using colony-formation assay, immunofluorescence, flow cytometry, and immunoblots.
Results
The results showed that Sftpc-/- mice demonstrated a reduced AT2 cell population. Influenza A virus subtype H1N1 (H1N1) infected Sftpc-/- mice demonstrated reduced AT2 proliferation and AT1 differentiation. Western blot indicated elevated levels of CD74 protein in AT2 cells of Sftpc-/- mice. Colony-forming efficiency was significantly attenuated in AT2 cells isolated from Sftpc-/- mice compared to the WT controls. Podoplanin (PDPN, a marker of AT1 cells) expression and transient cell count significantly increased in Sftpc-/- organoids. Moreover, siRNA-mediated gene silencing of CD74 in AT2 cells significantly increased AT2 proliferation and AT1 differentiation in Sftpc-/- organoids.
Conclusions
This study suggests that SPC regulates AT2 lineage in vitro and in vivo. The SPC might influence AT2 lineage during the lung epithelium repair by activating signaling mechanism involving CD74 receptor.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.
- Burn and Shock Trauma Research Institute, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.
- Department of Orthopedics and Rehabilitation, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.
- Infectious Diseases and Immunology Research Institute, Stritch School of Medicine, Loyola University Chicago, Maywood, IL 60153, USA.
- Department of Biostatistics and Data Science, University of Texas Medical Branch, Galveston, TX 77550, USA.
Förderung
- NHLBI NIH HHS
Zitieren
APA
Jain, K. G., Liu, Y., Zhao, R., Muire, P. J., Xi, N. M., & Ji, H. L. (2024). Surfactant Protein-C Regulates Alveolar Type 2 Epithelial Cell Lineages via the CD74 Receptor. Journal of Respiratory Biology and Translational Medicine. https://doi.org/10.70322/jrbtm.2024.10017
Vancouver
Jain KG, Liu Y, Zhao R, Muire PJ, Xi NM, Ji HL. Surfactant Protein-C Regulates Alveolar Type 2 Epithelial Cell Lineages via the CD74 Receptor. Journal of Respiratory Biology and Translational Medicine. 2024. doi:10.70322/jrbtm.2024.10017
BibTeX
@article{Jain2024,
author = {Jain, Krishan G and Liu, Yang and Zhao, Runzhen and Muire, Preeti J and Xi, Nan-Miles and Ji, Hong-Long},
title = {Surfactant Protein-C Regulates Alveolar Type 2 Epithelial Cell Lineages via the CD74 Receptor},
journal = {Journal of Respiratory Biology and Translational Medicine},
year = {2024},
doi = {10.70322/jrbtm.2024.10017}
}
EUVIMED